Article · Weight Maintenance

Why Weight Regain Happens After Stopping GLP-1 Medication: What the Research Shows

By Jo Howell HPD, DSFH, NCH (Reg) · Published 15 January 2026

A calm path winding gently into the distance at sunset, suggesting an ongoing journey

GLP-1 medications such as Wegovy (semaglutide) and Mounjaro (tirzepatide) have transformed the treatment of obesity and weight management.

Many people experience significant weight loss while taking these medications. Appetite often reduces, food cravings become less intrusive and thoughts about food may quieten considerably. For some individuals, it is the first time in years that managing their weight has felt less like a constant struggle.

However, as the use of these medications becomes more widespread, attention is increasingly turning to a different question: what happens when the medication stops?

The Statistic That Changed the Conversation

One of the most widely discussed findings comes from the STEP 1 Extension Study. Researchers followed participants after they stopped taking semaglutide and found that, on average, they regained around two-thirds of the weight they had lost within one year.

Maintaining weight loss after treatment presents a separate challenge from achieving weight loss in the first place.

At first glance, this statistic can feel discouraging. However, it is important to understand what the study does and does not tell us. Participants did not typically return to their original starting weight within the study period. Rather, the research demonstrated that maintenance is a distinct challenge — and it helped draw attention to an issue researchers are now examining in much greater detail: what happens after medication is reduced or stopped.

How GLP-1 Medications Work

GLP-1 medications influence several systems involved in appetite regulation. They slow gastric emptying, increase feelings of fullness and affect appetite-regulating centres within the brain. As a result, many people naturally consume fewer calories without feeling they are constantly relying on willpower.

While taking the medication, eating decisions may feel easier. Hunger is often reduced and cravings can become less frequent or less intense. When treatment stops, many of these effects begin to diminish.

Why Weight Regain Can Occur

Weight regain after stopping GLP-1 medication is not simply a matter of old habits returning. Weight loss triggers a number of biological adaptations designed to encourage the body to regain lost weight. Hunger-related hormones can increase while satiety signals decrease. At the same time, energy expenditure often falls, meaning the body requires fewer calories than before to maintain itself.

From an evolutionary perspective, this response is understandable. Human biology evolved to protect against weight loss and famine rather than excess calorie availability. The challenge is that these adaptations can persist long after weight has been lost, making maintenance more difficult than many people expect.

Why This Matters

For many people, the experience of taking GLP-1 medication is not simply about eating less. It can be the first time in years that appetite feels manageable, cravings become quieter and decisions around food require less effort.

When some of those effects begin to reverse after treatment ends, people often assume they have somehow failed or lacked discipline. Current evidence suggests the picture is considerably more complex than this. Weight regulation is influenced by a combination of biological, psychological and environmental factors. The return of appetite and food-related thoughts following treatment appears to be driven, at least in part, by physiological processes rather than simply a lack of willpower.

Understanding this distinction is important because it shifts the conversation away from blame and towards a more accurate understanding of long-term weight management.

The Return of Appetite and Food Noise

Many people describe a noticeable reduction in food noise while taking GLP-1 medication. Food noise is not a formal medical term, but it is widely used to describe persistent thoughts about food, eating and cravings.

When medication is withdrawn, these thoughts may begin to return. Appetite may increase and individuals may find themselves thinking about food more frequently than they did during treatment. This does not necessarily mean a person has lost control or failed. Rather, it reflects the fact that the biological effects of the medication are no longer present to the same degree.

Does Everyone Regain Weight?

Although weight regain is common, outcomes vary considerably between individuals. Some people maintain a substantial proportion of their weight loss long term. Others regain only a small amount. Researchers are still investigating why some individuals appear better able to maintain weight loss than others.

Possible explanations include established changes in eating habits, ongoing lifestyle support, differences in individual biology, physical activity levels and long-term changes in appetite regulation. The picture is therefore more nuanced than the headlines sometimes suggest.

What Does This Mean for Long-Term Weight Maintenance?

Current evidence suggests that successful weight maintenance is likely to involve more than a single intervention. Medication can play an important role in reducing appetite and supporting weight loss. However, long-term outcomes also appear to be influenced by behavioural, psychological and environmental factors.

Researchers continue to investigate the role of eating patterns, stress, sleep, physical activity, habits and ongoing support in helping people maintain weight loss over time. Although many questions remain, there is growing recognition that long-term weight management involves more than simply reducing calorie intake. It is increasingly viewed as a complex interaction between biology, behaviour and environment.

What Current Research Is Exploring

Researchers are increasingly focusing on weight maintenance rather than weight loss alone. Questions being explored include how long treatment should continue, what factors predict successful maintenance, whether behavioural interventions improve long-term outcomes and which individuals are most likely to benefit from ongoing treatment.

The answers are still emerging, but there is growing recognition that obesity behaves more like a chronic health condition than a short-term problem with a clear endpoint.

Key takeaways

Weight regain after stopping GLP-1 medication is common.
Biological changes in appetite and energy expenditure appear to play an important role.
The return of hunger and food noise can make maintenance more challenging.
Outcomes vary considerably between individuals.
Long-term weight maintenance appears to involve biological, behavioural and environmental factors.

Conclusion

GLP-1 medications have provided an effective treatment option for many people living with obesity. However, the evidence suggests that maintaining weight loss after treatment can be challenging. Biological adaptations, returning appetite and changes in energy balance all appear to play a role.

As the use of GLP-1 medication continues to grow, the focus of research is increasingly shifting from weight loss alone to the challenge of long-term maintenance. Understanding what supports people after medication may prove just as important as understanding how the medication works in the first place.

Jo Howell, Solution Focused Hypnotherapist

Jo Howell HPD, DSFH, NCH (Reg)

Jo is a Solution Focused Hypnotherapist and founder of Life Beyond Jabs. With a background in education and behaviour change, she has a particular interest in the psychological and behavioural factors that influence long-term weight management and weight maintenance following GLP-1 medication.